Share capital increase registered - Correction*

10. Dec 2021 | 1 min read

Moss, 9 December 2021

Reference is made to the stock exchange notice from Gentian Diagnostics ASA (the
"Company") on 29 November 2021 regarding a share issue in connection with an
employee share purchase program (ESPP), by issuance of *10,461 new shares in the
Company at a subscription price of NOK 54.49 per new share. The share capital
increase pertaining to the ESPP is now registered with the Norwegian Register of
Business Enterprises. The Company's new registered share capital is NOK
1,542,235.0 divided on 15,422,350 shares, each with a nominal value of NOK 0.10.

This information is subject to the disclosure requirements pursuant to section
5-12 of the Norwegian Securities Trading Act.

For further information, please contact:

Njaal Kind
CFO, Gentian Diagnostics
Cell Phone: +47 919 06 525

You may also read

Dec 17, 2021 - Kristin Hart

Financial calendar

Financial calendar for Gentian Diagnostics ASA  

Dec 16, 2021 - Kristin Hart

Completed development of SARS CoV-2 antibody assay

Moss, 16 December 2021 Gentian Diagnostics ASA, a fast-growing developer and manufacturer of innovative and..